roflumilast,tapinarof
astrazeneca,dermavant
['roflumilast', 'tapinarof']
congress #wcd2023singapore | mark g lebwohl discussed promising efficacy &amp; safety data from individual clinical trials of new topical therapies: roflumilast (phosphodiesterase-4 inhibitor) &amp; tapinarof (aryl hydrocarbon receptor agonist) in patients with 
The Psoriasis and Psoriatic Arthritis Hub is an open-access online resource that provides balanced and up-to-date medical education. #Psoriasis #RheumTwitter